DT
CAI

Diversified Trust’s Caris Life Sciences CAI Stock Holding History

Diversified Trust’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$665K Buy
37,325
+4,825
+15% +$86.4K 0.01% 662
2026
Q1 		$581K Buy
32,500
+12,500
+63% +$273K 0.01% 641
2025
Q4 		$540K Buy
+20,000
New +$563K 0.01% 638

Other funds holding CAI

ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Diversified Trust's CAI Position: Q2 2026 in Review

Diversified Trust increased its Caris Life Sciences (CAI) stake by 15% in Q2 2026, buying an estimated $86.4K and bringing the position to 37,325 shares worth $665K. The position accounts for 0.01% of the portfolio, ranked #662.

Diversified Trust first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. 44 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Diversified Trust held 37,325 shares of Caris Life Sciences worth $665K as of Q2 2026.
  • Diversified Trust bought 4,825 Caris Life Sciences shares in Q2 2026, an estimated $86.4K.
  • Caris Life Sciences made up 0.01% of Diversified Trust's portfolio in Q2 2026, its #662 holding.
  • Diversified Trust first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 44 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.